{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T19:43:07Z","timestamp":1788291787198,"version":"build-2803163510"},"reference-count":38,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Grifols\u00a9 Shared Services North America, Inc"},{"name":"Grifols\u00a9 Shared Services North America, Inc"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines & Immunotherapeutics"],"published-print":{"date-parts":[[2020,1,2]]},"DOI":"10.1080\/21645515.2019.1632680","type":"journal-article","created":{"date-parts":[[2019,6,18]],"date-time":"2019-06-18T11:21:02Z","timestamp":1560856862000},"page":"51-60","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":22,"title":["Adherence to guideline recommendations for human rabies immune globulin patient selection, dosing, timing, and anatomical site of administration in rabies postexposure prophylaxis"],"prefix":"10.1080","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2075-5502","authenticated-orcid":false,"given":"Grace S.","family":"Hwang","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Houston Methodist Hospital, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1390-1409","authenticated-orcid":false,"given":"Elsie","family":"Rizk","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Houston Methodist, Houston, TX, USA"},{"name":"Department of Pharmacy Research, Houston Methodist Research Institute, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9048-8094","authenticated-orcid":false,"given":"Lan N.","family":"Bui","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, Samford University McWhorter School of Pharmacy, Birmingham, AL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5251-3778","authenticated-orcid":false,"given":"Tomona","family":"Iso","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Houston Methodist, Houston, TX, USA"},{"name":"Department of Pharmacy Research, Houston Methodist Research Institute, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4667-8074","authenticated-orcid":false,"given":"Emily I.","family":"Sartain","sequence":"additional","affiliation":[{"name":"College of Pharmacy, University of Texas at Austin, Austin, TS, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9605-936X","authenticated-orcid":false,"given":"Anh Thu","family":"Tran","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Texas A&M University, College Station, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6390-2322","authenticated-orcid":false,"given":"Joshua T.","family":"Swan","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Houston Methodist, Houston, TX, USA"},{"name":"Departments of Surgery and Pharmacy in the Institute for Academic Medicine, Houston Methodist Research Institute, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2019,8]]},"reference":[{"key":"e_1_3_5_2_1","doi-asserted-by":"publisher","DOI":"10.1086\/313632"},{"key":"e_1_3_5_3_1","first-page":"1","article-title":"Human rabies prevention\u2013United States, 2008: recommendations of the advisory committee on immunization practices","volume":"57","author":"SE Manning","year":"2008","unstructured":"Manning SE, Rupprecht CE, Fishbein D, Hanlon CA, Lumlertdacha B, Guerra M, Meltzer MI, Dhankhar P, Vaidya SA, Jenkins SR, et al. Human rabies prevention\u2013United States, 2008: recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep. 2008;57:1\u201328.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2018.07.001"},{"key":"e_1_3_5_5_1","unstructured":"Centers for Disease Control and Prevention. Rabies-Exposure to the Virus. 2011. [Accessed 2019 January 11]. https:\/\/www.cdc.gov\/rabies\/transmission\/exposure.html"},{"key":"e_1_3_5_6_1","unstructured":"Centers for Disease Control and Prevention. Human Rabies. 2017. [Accessed 2019 Jan 10]. https:\/\/www.cdc.gov\/rabies\/location\/usa\/surveillance\/human_rabies.html"},{"key":"e_1_3_5_7_1","first-page":"1","article-title":"Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies: recommendations of the advisory committee on immunization practices","volume":"59","author":"Rupprecht CE","year":"2010","unstructured":"Rupprecht CE, Briggs D, Brown CM, Franka R, Katz SL, Kerr HD, Lett SM, Levis R, Meltzer MI, Schaffner W, et al. Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies: recommendations of the advisory committee on immunization practices. MMWR. 2010;59:1\u20139.","journal-title":"MMWR"},{"key":"e_1_3_5_8_1","first-page":"759","article-title":"Human rabies despite treatment with rabies immune globulin and human diploid cell rabies vaccine\u2013thailand","volume":"36","author":"Centers for Disease Control and Prevention","year":"1987","unstructured":"Centers for Disease Control and Prevention. Human rabies despite treatment with rabies immune globulin and human diploid cell rabies vaccine\u2013thailand. MMWR Morb Mortal Wkly Rep. 1987;36:759\u201360.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198705143162006"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198801143180219"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(89)90157-6"},{"key":"e_1_3_5_12_1","first-page":"1","article-title":"General recommendations on immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"43","author":"Advisory Committee on Immunization Practices","year":"1994","unstructured":"Advisory Committee on Immunization Practices. General recommendations on immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 1994;43:1\u201338.","journal-title":"MMWR"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.4103\/ijccm.IJCCM_521_17"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(61)80158-3"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1998.89.1.0013"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1177\/0300060514531924"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-1157(82)80013-9"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(95)00213-K"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(88)90225-3"},{"key":"e_1_3_5_20_1","first-page":"303","article-title":"Rabies immune globulin of human origin: preparation and dosage determination in non-exposed volunteer subjects","volume":"45","author":"Cabasso VJ","year":"1971","unstructured":"Cabasso VJ, Loofbourow JC, Roby RE, Anuskiewicz W. Rabies immune globulin of human origin: preparation and dosage determination in non-exposed volunteer subjects. Bull World Health Organ. 1971;45:303\u201315.","journal-title":"Bull World Health Organ"},{"key":"e_1_3_5_21_1","unstructured":"World Health Organization. Rabies. 2018. [Accessed 2019 January 10]. https:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/rabies"},{"key":"e_1_3_5_22_1","first-page":"477","article-title":"Studies on the local treatment of rabies-infected wounds","volume":"28","author":"Dean DJ","year":"1963","unstructured":"Dean DJ, Baer GM, Thompson WR. Studies on the local treatment of rabies-infected wounds. Bull World Health Organ. 1963;28:477\u201386.","journal-title":"Bull World Health Organ"},{"key":"e_1_3_5_23_1","first-page":"1","article-title":"An evaluation of the safety and potency of equine rabies immunoglobulin through measurements of suppression on vaccine induced antibody production among healthy volunteers","volume":"52","author":"Salva EP","year":"2014","unstructured":"Salva EP, Dimaano EM, Villarama JB, Suquilla JT. An evaluation of the safety and potency of equine rabies immunoglobulin through measurements of suppression on vaccine induced antibody production among healthy volunteers. Philip J Inte Med. 2014;52:1\u20137.","journal-title":"Philip J Inte Med"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/TME.0b013e31828f0b79"},{"key":"e_1_3_5_25_1","unstructured":"National Health Service. Clinical guidelines for immunoglobulin use (second edition update). 2012. [Accessed 2018 December 18]. https:\/\/www.nsd.scot.nhs.uk\/Documents\/clinimmumoMarch12.pdf"},{"key":"e_1_3_5_26_1","doi-asserted-by":"crossref","unstructured":"Fahrenbruch R Kintzel P Bott AM Gilmore S Markham R. Dose Rounding of biologic and cytotoxic anticancer agents: a position statement of the Hematology\/Oncology Pharmacy Association. J Oncol Pract. 2018;14:e130-e6.","DOI":"10.1200\/JOP.2017.025411"},{"key":"e_1_3_5_27_1","unstructured":"HyperRab\u00ae [rabies immune globulin (human)] [package insert]. Grifols Therapeutics Inc. Research Triangle Park (NC). 2018."},{"key":"e_1_3_5_28_1","unstructured":"HyperRab\u00ae S\/D (rabies immune globulin [human]) [package insert]. Grifols Therapeutics Inc. Clayton (NC). 2012."},{"key":"e_1_3_5_29_1","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1542\/peds.70.6.944","article-title":"Intramuscular injections in children","volume":"70","author":"Bergeson PS","year":"1982","unstructured":"Bergeson PS, Singer SA, Kaplan AM. Intramuscular injections in children. Pediatrics. 1982;70:944\u201348.","journal-title":"Pediatrics"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.2460\/javma.250.10.1117"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.2460\/javma.253.12.1555"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2015.1085142"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2016.1255834"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/22.2.228"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(89)90185-0"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.09.036"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jemermed.2004.02.005"},{"key":"e_1_3_5_38_1","unstructured":"World Health Organization. Weekly epidemiological record No 16. 2018. [Accessed 2019 April 17]. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/272371\/WER9316.pdf?ua=1"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.2147\/CPAA.S166454"}],"container-title":["Human Vaccines & Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2019.1632680","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T08:37:38Z","timestamp":1710232658000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2019.1632680"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1,2]]}},"alternative-id":["10.1080\/21645515.2019.1632680"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2019.1632680","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.736011829.793578886","asserted-by":"object"}]},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2019-04-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-06-11","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-08-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}